METHODS AND SYSTEMS FOR PREDICTING RESPONSE OF CELLS TO A THERAPEUTIC AGENT

摘要

Disclosed is an anti-ErbB3 antibody for use in the manufacture of a medicament for treating a patient having a neoplastic tumor, wherein a sample of the tumor obtained from the patient is characterized by a level of phosphorylated ErbB3 (pErbB3) no lower than 0.064 pg/ìg total protein.